Evaluating the Clinical Impact of BioFire Spotfire R/ST on the Management of Pediatric Respiratory Presentations in the Emergency Department: A Pre–Post Cross-Sectional Study in Chile
Viruses · 2026
DOI: 10.3390/v18010139 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Viruses, 2026. Verfasst von Dona Benadof und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio Clínico, Hospital Roberto del Rio, Santiago 8380457, Chile. Hauptthemen laut MEDLINE: Respiratory Tract Infections, Emergency Service, Hospital. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center of Excellence (CoE) CEO Grant.
Abstract (Originalsprache)
Respiratory infections represent one of the leading causes of pediatric consultations and hospitalizations in Chile, where rapid etiological identification is essential for clinical decision-making. We evaluated the impact of implementing the BIOFIRE® SPOTFIRE® Respiratory (R) Panel in the pediatric Emergency Department of a public referral hospital in Santiago, using a pre–post cross-sectional design comparing two winter periods (July 2023 vs. July 2024). Clinical records, laboratory data, and operational indicators were analyzed to assess changes in diagnostic yield, turnaround time, hospitalizations, discharges, supplementary test requests, and antimicrobial use. A total of 470 patients were included (224 in 2023; 246 in 2024). The etiological detection rate increased from 58.0% to 87.8% after the implementation of Spotfire® (p < 0.0001), with marked increases in the identification of adenovirus, RSV, rhinovirus/enterovirus, and seasonal coronaviruses. Rapid molecular testing was associated with a significant rise in emergency department discharges (23.7% vs. 57.3%; p < 0.0001) and a reduction in hospitalizations (76.3% vs. 42.7%; p < 0.0001) and readmissions (9.2% vs. 0.5%; p < 0.0001). Requests for complete blood counts, chest X-rays, and antimicrobial prescriptions at discharge also decreased significantly. These effects persisted in key subgroups, including infants and children with comorbidities. In this high-demand winter setting, the BIOFIRE® SPOTFIRE® R Panel improved diagnostic performance and supported more efficient and targeted clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio Clínico, Hospital Roberto del Rio, Santiago 8380457, Chile.
- Departamento de Pediatría y Cirugía, Facultad de Medicina, Universidad de Chile, Santiago 8380456, Chile.
- Centro de Investigación Clínica y Avanzada, Facultad de Medicina, Universidad de Chile, Santiago 8380456, Chile.
- Unidad de Infectología, Hospital Roberto del Rio, Santiago 8380457, Chile.
- Departamento de Procesos Terapéuticos, Facultad de Ciencias de la Salud, Universidad Católica de Temuco, Temuco 4780000, Chile.
ORCID-Profile: Daniel Conei
Förderung
- Center of Excellence (CoE) CEO Grant
Zitieren
APA
Benadof, D., Acuña, M., Leiva, Y., & Conei, D. (2026). Evaluating the Clinical Impact of BioFire Spotfire R/ST on the Management of Pediatric Respiratory Presentations in the Emergency Department: A Pre–Post Cross-Sectional Study in Chile. Viruses. https://doi.org/10.3390/v18010139
Vancouver
Benadof D, Acuña M, Leiva Y, Conei D. Evaluating the Clinical Impact of BioFire Spotfire R/ST on the Management of Pediatric Respiratory Presentations in the Emergency Department: A Pre–Post Cross-Sectional Study in Chile. Viruses. 2026. doi:10.3390/v18010139
BibTeX
@article{Benadof2026,
author = {Benadof, Dona and Acuña, Mirta and Leiva, Yennybeth and Conei, Daniel},
title = {Evaluating the Clinical Impact of BioFire Spotfire R/ST on the Management of Pediatric Respiratory Presentations in the Emergency Department: A Pre–Post Cross-Sectional Study in Chile},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18010139}
}
EUVIMED